Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2021

01-02-2021 | Breast Cancer | Epidemiology

The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer

Authors: Kelly A. Metcalfe, Alexandra Candib, Vasily Giannakeas, Andrea Eisen, Aletta Poll, David McCready, Tulin Cil, Frances C. Wright, Susan Armel, Karen Ott, Ping Sun, Steven A. Narod

Published in: Breast Cancer Research and Treatment | Issue 1/2021

Login to get access

Abstract

Purpose

Many women with early-onset breast cancer experience adverse psychological sequelae which impact on their quality of life. We sought to correlate levels of anxiety and cancer-related distress in women with breast cancer shortly after surgery and one year after treatment with the estimated risk of death.

Methods

We studied 596 women with Stage I to III breast cancer. For each woman we estimated the five-year risk of death based on SEER data from 2010 to 2019. For each woman we measured anxiety and cancer-related distress levels shortly after surgery and one year later.

Results

The mean estimated five-year survival was 95%. At one week post-surgery, 59% of women had a clinically significant level of anxiety and 74% had a clinically significant level of cancer-related distress. There was no correlation between the objective risk of death and the level of anxiety or distress, at one week or at one year.

Conclusions

Many women diagnosed with early-stage breast cancers experience significant levels of anxiety and distress. The emotional response to a breast cancer diagnosis is not related to the risk of death per se and other factors should be explored.
Literature
1.
go back to reference Brenner D, Weir HK, Demers AA, Ellison LF, Louzado C, Shaw A et al (2020) Projected burden of cancer in Canada in 2020. Can Med Assoc J 192(9):E199–E205CrossRef Brenner D, Weir HK, Demers AA, Ellison LF, Louzado C, Shaw A et al (2020) Projected burden of cancer in Canada in 2020. Can Med Assoc J 192(9):E199–E205CrossRef
2.
go back to reference Narod SA, Giannakeas V, Sopik V (2019) Late recurrences after estrogen receptor-positive breast cancer. JAMA Oncol 6(2):301–302 Narod SA, Giannakeas V, Sopik V (2019) Late recurrences after estrogen receptor-positive breast cancer. JAMA Oncol 6(2):301–302
3.
go back to reference Holland JC, Andersen B, Breitbart WS, Buchmann LO, Compas B, Deshields TL et al (2013) Distress management. J Natl Compr Cancer Netw 11(2):190–209CrossRef Holland JC, Andersen B, Breitbart WS, Buchmann LO, Compas B, Deshields TL et al (2013) Distress management. J Natl Compr Cancer Netw 11(2):190–209CrossRef
4.
go back to reference Riba MB, Donovan KA, Andersen B, Braun I, Breitbart WS, Brewer BW et al (2019) Distress management, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 17(10):1229–1249CrossRef Riba MB, Donovan KA, Andersen B, Braun I, Breitbart WS, Brewer BW et al (2019) Distress management, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 17(10):1229–1249CrossRef
5.
go back to reference Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 330(7493):702CrossRef Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 330(7493):702CrossRef
6.
go back to reference Carlson LE, Waller A, Groff SL, Giese-Davis J, Bultz BD (2013) What goes up does not always come down: patterns of distress, physical and psychosocial morbidity in people with cancer over a one year period. Psychooncology 22(1):168–176CrossRef Carlson LE, Waller A, Groff SL, Giese-Davis J, Bultz BD (2013) What goes up does not always come down: patterns of distress, physical and psychosocial morbidity in people with cancer over a one year period. Psychooncology 22(1):168–176CrossRef
7.
go back to reference Stafford L, Judd F, Gibson P, Komiti A, Mann GB, Quinn M (2015) Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome. Support Care Cancer 23(8):2215–2224CrossRef Stafford L, Judd F, Gibson P, Komiti A, Mann GB, Quinn M (2015) Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome. Support Care Cancer 23(8):2215–2224CrossRef
8.
go back to reference Batty GD, Russ TC, Stamatakis E, Kivimaki M (2017) Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies. BMJ 356:j108CrossRef Batty GD, Russ TC, Stamatakis E, Kivimaki M (2017) Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies. BMJ 356:j108CrossRef
9.
go back to reference Syrowatka A, Motulsky A, Kurteva S, Hanley JA, Dixon WG, Meguerditchian AN et al (2017) Predictors of distress in female breast cancer survivors: a systematic review. Breast Cancer Res Treat 165(2):229–245CrossRef Syrowatka A, Motulsky A, Kurteva S, Hanley JA, Dixon WG, Meguerditchian AN et al (2017) Predictors of distress in female breast cancer survivors: a systematic review. Breast Cancer Res Treat 165(2):229–245CrossRef
10.
go back to reference Horowitz M, Wilner N, Alvarez W (1979) Impact of event scale: a measure of subjective stress. Psychosom Med 41(3):209–218CrossRef Horowitz M, Wilner N, Alvarez W (1979) Impact of event scale: a measure of subjective stress. Psychosom Med 41(3):209–218CrossRef
11.
go back to reference Snaith RP, Zigmond AS (1986) The hospital anxiety and depression scale. Br Med J 292(6516):344CrossRef Snaith RP, Zigmond AS (1986) The hospital anxiety and depression scale. Br Med J 292(6516):344CrossRef
12.
go back to reference Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRef Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRef
13.
go back to reference Stern AF (2014) The hospital anxiety and depression scale. Occup Med (Lond) 64(5):393–394CrossRef Stern AF (2014) The hospital anxiety and depression scale. Occup Med (Lond) 64(5):393–394CrossRef
14.
go back to reference Olsson I, Mykletun A, Dahl AA (2005) The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 5:46CrossRef Olsson I, Mykletun A, Dahl AA (2005) The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 5:46CrossRef
15.
go back to reference Ruddy KJ, Meyer ME, Giobbie-Hurder A, Emmons KM, Weeks JC, Winer EP et al (2013) Long-term risk perceptions of women with ductal carcinoma in situ. Oncologist 18(4):362–368CrossRef Ruddy KJ, Meyer ME, Giobbie-Hurder A, Emmons KM, Weeks JC, Winer EP et al (2013) Long-term risk perceptions of women with ductal carcinoma in situ. Oncologist 18(4):362–368CrossRef
16.
go back to reference Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M et al (2008) Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst 100(4):243–251CrossRef Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M et al (2008) Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst 100(4):243–251CrossRef
17.
go back to reference Hawley ST, Janz NK, Griffith KA, Jagsi R, Friese CR, Kurian AW et al (2017) Recurrence risk perception and quality of life following treatment of breast cancer. Breast Cancer Res Treat 161(3):557–565CrossRef Hawley ST, Janz NK, Griffith KA, Jagsi R, Friese CR, Kurian AW et al (2017) Recurrence risk perception and quality of life following treatment of breast cancer. Breast Cancer Res Treat 161(3):557–565CrossRef
18.
go back to reference Kelly KM, Ajmera M, Bhattacharjee S, Vohra R, Hobbs G, Chaudhary L et al (2013) Perception of cancer recurrence risk: more information is better. Patient Educ Couns 90(3):361–366CrossRef Kelly KM, Ajmera M, Bhattacharjee S, Vohra R, Hobbs G, Chaudhary L et al (2013) Perception of cancer recurrence risk: more information is better. Patient Educ Couns 90(3):361–366CrossRef
19.
go back to reference Tan AS, Nagler RH, Hornik RC, DeMichele A (2015) Evolving information needs among colon, breast, and prostate cancer survivors: results from a longitudinal mixed-effects analysis. Cancer Epidemiol Biomark Prev 24(7):1071–1078CrossRef Tan AS, Nagler RH, Hornik RC, DeMichele A (2015) Evolving information needs among colon, breast, and prostate cancer survivors: results from a longitudinal mixed-effects analysis. Cancer Epidemiol Biomark Prev 24(7):1071–1078CrossRef
20.
go back to reference Zikmund-Fisher BJ, Janz NK, Hawley ST, Griffith KA, Sabolch A, Jagsi R (2016) Communication of recurrence risk estimates to patients diagnosed with breast cancer. JAMA Oncol 2(5):684–686CrossRef Zikmund-Fisher BJ, Janz NK, Hawley ST, Griffith KA, Sabolch A, Jagsi R (2016) Communication of recurrence risk estimates to patients diagnosed with breast cancer. JAMA Oncol 2(5):684–686CrossRef
21.
go back to reference Janz NK, Leinberger RL, Zikmund-Fisher BJ, Hawley ST, Griffith K, Jagsi R (2015) Provider perspectives on presenting risk information and managing worry about recurrence among breast cancer survivors. Psychooncology 24(5):592–600CrossRef Janz NK, Leinberger RL, Zikmund-Fisher BJ, Hawley ST, Griffith K, Jagsi R (2015) Provider perspectives on presenting risk information and managing worry about recurrence among breast cancer survivors. Psychooncology 24(5):592–600CrossRef
Metadata
Title
The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer
Authors
Kelly A. Metcalfe
Alexandra Candib
Vasily Giannakeas
Andrea Eisen
Aletta Poll
David McCready
Tulin Cil
Frances C. Wright
Susan Armel
Karen Ott
Ping Sun
Steven A. Narod
Publication date
01-02-2021
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2021
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-05992-w

Other articles of this Issue 1/2021

Breast Cancer Research and Treatment 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine